A RETROSPECTIVE ANALYSIS OF THE EFFICACY AND SAFETY OF REGORAFENIB IN PATIENTS WITH CHEMO-REFRACTORY COLORECTAL CANCER

被引：0
|
作者：
Oishi, Takayuki [1 ]
Takahashi, Masanobu [2 ]
Shiono, Masatoshi [2 ]
Takahashi, Shin [1 ]
Akiyama, Shoko [2 ]
Shirota, Hidekazu [2 ]
Shimodaira, Hideki [2 ]
Kato, Shunsuke [1 ]
Ishioka, Chikashi [1 ]
机构：
[1] Tohoku Univ, IDAC, Dept Clin Oncol, Sendai, Miyagi 980, Japan
[2] Tohoku Univ Hosp, Dept Clin Oncol, Sendai, Miyagi, Japan
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu436.27
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-12-2
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Regorafenib Versus Trifluridine/Tipiracil for Refractory Metastatic Colorectal Cancer: A Retrospective Comparison
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Hamauchi, Satoshi
    Komori, Azusa
    Kito, Yosuke
    Narita, Yukiya
    Tsushima, Takahiro
    Ishihara, Makoto
    Todaka, Akiko
    Tanaka, Tsutomu
    Yokota, Tomoya
    Kadowaki, Shigenori
    Machida, Nozomu
    Ura, Takashi
    Fukutomi, Akira
    Ando, Masashi
    Onozawa, Yusuke
    Tajika, Masahiro
    Yasui, Hirofumi
    Muro, Kei
    Mori, Keita
    Yamazaki, Kentaro
    CLINICAL COLORECTAL CANCER, 2017, 16 (02) : E15 - E22
  • [42] HGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction
    Ishiguro, A.
    Yuki, S.
    Nakano, S.
    Kawamoto, Y.
    Sawada, K.
    Tsuji, Y.
    Honda, T.
    Miyagishima, T.
    Yoshida, S.
    Hatanaka, K.
    Sasaki, T.
    Muto, O.
    Ohnuma, H.
    Kato, S.
    Sato, A.
    Abe, M.
    Kato, K.
    Amano, T.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 36 - 36
  • [43] HGCSG1401: A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer: Analysis of risk factors for liver dysfunction
    Honda, T.
    Yuki, S.
    Muranaka, T.
    Nakatsumi, H.
    Tsuji, Y.
    Miyagishima, T.
    Yoshida, S.
    Hatanaka, K.
    Sasaki, T.
    Ishiguro, A.
    Muto, O.
    Ohnuma, H.
    Kato, S.
    Sato, A.
    Abe, M.
    Kato, K.
    Onodera, K.
    Eto, K.
    Tateyama, M.
    Amano, T.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [44] Case report: Efficacy and safety of regorafenib plus fluorouracil combination therapy in the treatment of refractory metastatic colorectal cancer
    Haque, Emaan
    Muhsen, Ibrahim N.
    Esmail, Abdullah
    Umoru, Godsfavour
    Mylavarapu, Charisma
    Ajewole, Veronica B.
    Abdelrahim, Maen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [45] Clinical Value Of Apatinib As A Salvage Treatment In Patients With Chemo-Refractory Advanced Cervical Cancer
    Su, Meng
    Gao, Ya
    Ye, XuXue
    Zhou, QingYu
    Zhao, LiHao
    Cai, Xiaona
    Chen, Didi
    Su, Huafang
    Zhang, Xiaohua
    Xie, Congying
    ONCOTARGETS AND THERAPY, 2019, 12 : 9707 - 9713
  • [46] Multi-omics characterization of chemo-refractory HGSC patients
    Muranen, Taru A.
    Rajavuori, Anna
    Afenteva, Daria
    Huhtinen, Kaisa
    Isoviita, Veli-Matti
    Jamalzadeh, Sanaz
    Lahtinen, Alexandra
    Lavikka, Kari
    Li, Yilin
    Marchi, Giovanni
    Oikkonen, Jaana
    Zhang, Kaiyang
    Virtanen, Anni
    Hynninen, Johanna
    Hautaniemi, Sampsa
    CANCER RESEARCH, 2023, 83 (07)
  • [47] Efficacy, safety and prognostic subgroups for outcome with regorafenib in patients with refractory metastatic colorectal cancer in the real-world setting: The CORE study
    Martinez-Lago, N.
    Carnero Lopez, B.
    de la Camara Gomez, J.
    Vazquez-Rivera, F.
    Fernandez Montes, A.
    Cousillas Castineiras, A.
    de Dios, N.
    Varela Ponte, R.
    Reboredo-Lopez, M.
    ANNALS OF ONCOLOGY, 2022, 33 : S269 - S270
  • [48] Efficacy and safety of regorafenib in the treatment of metastatic colorectal cancer: A systematic review
    Skarderud, Maria Roed
    Polk, Anne
    Vistisen, Kirsten Kjeldgaard
    Larsen, Finn Ole
    Nielsen, Dorte Lisbet
    CANCER TREATMENT REVIEWS, 2018, 62 : 61 - 73
  • [49] A Systematic Review and Meta-Analysis of the Efficacy and Safety of Regorafenib in the Treatment of Metastatic Colorectal Cancer
    Liang, Bingjun
    Tang, Ming
    Huang, Chao
    Yang, Yidian
    He, Yue
    Liao, Shengrong
    Shen, Weizeng
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [50] A retrospective cohort study evaluating the safety and efficacy of regorafenib in patients with metastatic colorectal cancer; The HGCSG1401 study - first report
    Dazai, M.
    Yuki, S.
    Muranaka, T.
    Yoshida, S.
    Ohta, Y.
    Hatanaka, K.
    Tsuji, Y.
    Ohta, T.
    Sato, A.
    Eto, K.
    Onodera, K.
    Sato, Y.
    Kato, K.
    Nakamura, M.
    Muto, O.
    Ishiguro, A.
    Tateyama, M.
    Okuda, H.
    Sakata, Y.
    Komatsu, Y.
    ANNALS OF ONCOLOGY, 2015, 26 : 48 - 48
12345